Aarti Drugs Buyback 2024 vs Weizmann Buyback 2024

Comparison between Aarti Drugs Buyback 2024 and Weizmann Buyback 2024.

Buyback Details

Aarti Drugs Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Weizmann Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.

 Aarti Drugs Ltd.Weizmann Ltd.
LogoAarti Drugs Buyback 2024 LogoWeizmann Buyback 2024 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹10 per share₹10 per share
Buyback Price₹900 per share₹160 per share
Issue Size6,65,000 shares3,65,169 shares
Issue Size (Amount)₹59.85 Crores₹5.84 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders9 Equity Shares out of every 706 Fully paid-up Equity Shares held on the Record Date.99,750
General Category for all other Eligible Shareholders5 Equity Shares out of every 744 Fully paid-up Equity Shares held on the Record Date.5,65,250
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders33 Equity Shares out of every 776 Fully paid-up Equity Shares held on the Record Date.62,763
General Category for all other Eligible Shareholders33 Equity Shares out of every 776 Fully paid-up Equity Shares held on the Record Date.3,02,406
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersInga Ventures Pvt.Ltd.Saffron Capital Advisors Pvt.Ltd.
Necessity of the buyback

The Company is proposing the Buyback to service the equity more efficiently. Additionally, the Company’s management strives to increase equity shareholder's value and the Buyback would result in amongst other things:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares;
  2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by a reduction in the equity base, thereby leading to a long-term increase in shareholders’ value;
  3. The Buyback gives an option to the shareholders holding Equity Shares of the Company, either to sell their Equity Shares and receive cash or not to sell their Equity Shares and get a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment; and
  4. The Buyback, which is being implemented through the tender offer as prescribed under the Buyback Regulations, would involve a minimum reservation of 15% for Small Shareholders and allocation of a higher number of shares as per their entitlement or 15% of the number of shares to be bought back, reserved for the Small Shareholders. The Company believes that this reservation for Small Shareholders would benefit a large number of public shareholders, who would be classified as Small Shareholders.

The Buyback is being undertaken for the following reasons:

  1. The buyback will help the company return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding.
  2. The buyback consists of up to 15% reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit many public shareholders who would be classified as "small shareholders".
  3. The buyback may help in improving financial ratios like return on equity, by reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Buyback Timetable

Aarti Drugs Buyback 2024 and Weizmann Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2024 Buyback record date is Sep 05, 2024. Weizmann Buyback 2024 Buyback record date is Aug 30, 2024.

 Aarti Drugs Ltd.Weizmann Ltd.
Record DateSep 05, 2024Aug 30, 2024
Offer Open DateSep 11, 2024Sep 05, 2024
Offer Closure DateSep 19, 2024Sep 11, 2024
Last date for receipt of tender formsSep 19, 2024Sep 11, 2024
Finalisation of buybackSep 25, 2024Sep 17, 2024
Last Date for settlment of bidsSep 26, 2024Sep 19, 2024
Last Date for extinguishment of sharesOct 08, 2024Sep 30, 2024

Financial Details and Other Relevent Information

Comparison of Aarti Drugs Buyback 2024 and Weizmann Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Aarti Drugs Ltd.Weizmann Ltd.
Financial

Aarti Drugs Ltd. Financial Information (Restated Consolidated)

Aarti Drugs Ltd.'s revenue decreased by -7% and profit after tax (PAT) rose by 3% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 202231 Mar 2021
Assets2,421.42,207.961,766.01
Revenue2,532.612,718.252,499.962,159.31
Profit After Tax171.59166.36205280.4
Net Worth1,262.071,173.691,016.62
Amount in ₹ Crore

Weizmann Ltd. Financial Information (Restated Consolidated)

Weizmann Ltd.'s revenue decreased by -8.93% and profit after tax (PAT) rose by 56.43% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets97.20101.87109.44
Revenue123.47135.57102.31
Profit After Tax9.586.122.88
Reserves and Surplus49.1840.5135.60
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2024 563.95 500.05 529.89
Jun-2024 538.90 450.20 507.91
May-2024 508.85 453.60 483.92

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2024 128.50 118.50 123.85
Jun-2024 155.10 107.05 122.10
May-2024 128.95 115.65 122.04
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2024 563.20 500.00 530.05
Jun-2024 538.95 451.05 508.13
May-2024 508.95 456.00 484.25

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2024 128.88 117.09 122.51
Jun-2024 154.58 108.15 121.89
May-2024 129.00 115.70 121.75

Compare with others

Compare:

Aarti Drugs Buyback 2024 and Weizmann Buyback 2024